Innovation Endeavors
Joel Dudley is a prominent figure in the fields of genetics, biomedical informatics, and precision medicine. As a Partner at Innovation Endeavors and an investor and board member for several companies including Think Bioscience, Harmonic Discovery, and Character Biosciences, Joel actively contributes to advancements in healthcare. Joel holds multiple prestigious positions at the Icahn School of Medicine at Mount Sinai, including Associate Professor of Genetics and Genomic Sciences, Endowed Chair of Biomedical Data Science, Director of the Institute for Next Generation Healthcare, and Director of Biomedical Informatics. Previous roles include Chief Scientific Advisor and Chief Scientific Officer at Tempus Labs, Inc., where Joel played a pivotal role in utilizing artificial intelligence to enhance precision medicine, and co-founder of Onegevity Health, which focuses on democratizing health information. Joel earned a PhD and MS in Biomedical Informatics from Stanford University and a BS in Microbiology from Arizona State University.
This person is not in any offices
Innovation Endeavors
Innovation Endeavors is helping entrepreneurs drive a super evolution of industry. A proliferation of data, advanced computation, and robotics are converging to accelerate iteration cycles, radically collapsing time. Innovation Endeavors invests in visionary founders, transformational technology, and emergent ecosystems for a new world. They have offices in Silicon Valley, Tel Aviv, and New York City.